The price of this share is at 116,26$, In this post we are going to talk about the listed company DexCom Inc, its leaders are Andrew K. Balo (EVP-Clinical Affairs, Regulatory Strategy), Jacob S. Leach (Chief Technology Officer & Executive VP), Jereme M Sylvain (SVP-Finance, Chief Financial & Accounting Officer), Kevin Ronald Sayer (Chairman, President & Chief Executive Officer), Shelly R. Selvaraj (Senior Vice President-Information Technology), they lead it to work in Medical/Dental Instruments especially in the North America region.
The closing price of the stock yesterday was desconocido$.
With an intraday difference of 115,87$ moving between 114,68$ and 117,05$, it is a notable difference that allows quick purchases and sales.
He earns an annual income of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
